← Taiwan Stock Snapshot Database

Home / Indicator library / Biotechnology and Medical Care / LI KANG (6242) overview

LI KANG (6242) stock overview

Valuation, financials, growth, ownership, events, dividends, models and adjusted prices for LI KANG, on one page

中文版 (Chinese)

LI KANG (6242) snapshot, key figures

Price / earnings
14.10x
Price / book
Dividend yield
5.81%
Revenue YoY (2026-06)
-8.3%
Monthly revenue (2026-06)
TWD 0.05bn
Sector
Biotechnology and Medical Care
Values above are the official-source snapshot for LI KANG (6242) on 2026-08-03. We do not chase live quotes. Every trading day is frozen as its own point-in-time vintage, so a backtest reading this data sees only what was actually knowable that day, with no look-ahead bias. Missing values stay blank. Nothing is interpolated or extrapolated.

LI KANG (6242): where today sits in the past year

Current value against the 2025-07-31 to 2026-07-31 range, built from 243 frozen daily vintages.

Price / earnings14.10x0th percentile of the past year
14.10xmedian 15.06x16.78x
Dividend yield5.81%100th percentile of the past year
4.66%median 5.17%5.81%
The marker is today's value; the faint tick is the one-year median. Every point in this range is the number as it was published on its own date, never a restated figure, so the percentile is what a reader on that day could actually have computed. Ratios at or below zero are excluded rather than treated as cheap. Tickers with fewer than 60 observed dates get no range at all.
Loading checkup signals…

Seven-dimension checkup for this ticker →

Valuation river

Loading…

Financial quality

Loading…

Revenue growth

Loading…

Ownership structure

Loading…

Events, last 90 days

Loading…

Yield river

Loading…

Valuation models

Loading…

Adjusted-price candles

Loading…

6242: common questions

What is 6242's P/E ratio?

6242 traded at a price-to-earnings ratio of 14.10x in the official-source snapshot dated 2026-08-03. That figure is frozen as a point-in-time vintage, so a backtest reading it sees only what was knowable that day.

What is 6242's dividend yield?

6242's cash dividend yield was 5.81% on 2026-08-03. Historical dividend policy and gap-fill records are available on the same page.

How fast is 6242's revenue growing?

6242 reported -8.3% year-on-year monthly revenue growth for 2026-06, from the official monthly revenue filing.

Is 6242's price / earnings high or low right now?

6242's price / earnings is 14.10x, which is below its one-year median of 15.06x and sits at the 0th percentile of the 14.10–16.78x range observed over the last 243 snapshot dates. Each of those dates is a frozen point-in-time vintage, so the range contains no restated or back-filled values.

Is 6242's dividend yield high or low right now?

6242's dividend yield is 5.81%, which is above its one-year median of 5.17% and sits at the 100th percentile of the 4.66–5.81% range observed over the last 243 snapshot dates. Each of those dates is a frozen point-in-time vintage, so the range contains no restated or back-filled values.

Other Biotechnology and Medical Care tickers

160 Taiwan-listed tickers sit in this sector. See the full Biotechnology and Medical Care table.

Everything on this page is either the official public source shown as-is, or a transparent derivation you can reproduce. The free tier covers 2330 in full as a reference case; on other tickers some blocks are paid-tier. What we sell is data and tooling, not investment advice, not stock tips, and not a promise of returns.